Ollete, Rogelio L.

HRN: 22-49-87  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/20/2023
01/27/2023
IV
500mg
Q8H
S/P Exlap For Perforated Gastric Ulcer Disease
Waiting Final Action 
01/20/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/20/2023
01/27/2023
IV
4.5g
Q8H
S/P Exlap For Perforated Gastric Ulcer Disease
Waiting Final Action 
02/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2023
02/09/2023
IV
500mg
Q8
S/p Exlap
Waiting Final Action 
02/02/2023
AMOXICILLIN 500MG CAPSULE (CAP)
02/02/2023
02/09/2023
PO
1000mg
BID
S/p Exlap
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: